𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Tumor Specific Transplantation Antigen

✍ Scribed by Pavel Koldovský M. D. (auth.)


Publisher
Springer-Verlag Berlin Heidelberg
Year
1969
Tongue
English
Leaves
82
Series
Recent Results in Cancer Research 22
Edition
1
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Table of Contents


Front Matter....Pages i-2
Methods of Induction of Antitumour Immunity....Pages 3-6
Methods of Detection of Antitumour Immunity....Pages 6-36
Immunity and Carcinogenesis....Pages 36-62
Summary and Perspectives....Pages 62-62
Back Matter....Pages 63-78

✦ Subjects


Medicine/Public Health, general


πŸ“œ SIMILAR VOLUMES


Prostate Specific Antigen
✍ Brawer πŸ“‚ Library πŸ“… 2001 🌐 English

Northwest Prostate Institute, Seattle, WA. Text covers the history of prostate specific antigen, biochemistry, variability of immunoassays for PSA, PSA density, PSA velocity, age-specific PSA, free and total PSA, early detection, repeat biopsy, alpha-1-antichymotrypsin, staging, radical prostatectom

Prostate Specific Antigen
✍ Brawer πŸ“‚ Library πŸ“… 2001 🌐 English

This state-of-the-art reference provides a comprehensive review of prostate specific antigen (PSA) and related prostate markers-examining velocity, density, and age-specific reference ranges for increased sensitivity in PSA tumor identification and selection of patient therapies. Supplemented with

Prostate Specific Antigen
✍ Brawer πŸ“‚ Library πŸ“… 2001 🌐 English

This state-of-the-art reference provides a comprehensive review of prostate specific antigen (PSA) and related prostate markers-examining velocity, density, and age-specific reference ranges for increased sensitivity in PSA tumor identification and selection of patient therapies. Supplemented with

Tumor Immunology: Molecularly Defined An
✍ Giorgio Parmiani πŸ“‚ Library πŸ“… 2003 πŸ› Not Avail 🌐 English

Recent advances in immunology and molecular biology have resulted in new therapeutic approaches being generated and implemented in cancer clinics. The discovery of new antigens, mechanisms of antigen presentation, and interplay of cells involved in anti-tumor immunity have made the clinical control